跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,168 条关于
“Nicotinamide Riboside Tartrate”
全部
1,168
临床试验
896
药物
205
机构
1
资讯
66
3个月前
Gundry MD Launches Elevate NAD+: NMN Supplement with Patent-Pending Beadlet Technology Targets Age-Related NAD+ Decline
4年前
ChromaDex Strengthens Patent Portfolio with Two New Continuation Patents for Nicotinamide Riboside Manufacturing
去年
Niagen Bioscience Secures Exclusive License for Nicotinamide Riboside as Parkinson's Disease Therapy
去年
First Clinical Trial Shows Nicotinamide Riboside Improves Multiple Health Outcomes in Werner Syndrome Patients
9个月前
Niagen Bioscience Acquires Core NAD+ Patent Portfolio from Queen's University Belfast
去年
Vitamin B3 Shows Promise in Reducing Lung Inflammation in COPD Patients
去年
Liquid Fat Supplement Shows Promise in Treating Rare Childhood Disease Ataxia-Telangiectasia
3个月前
Neuroprotection in Glaucoma: From Memantine's Failure to Nicotinamide's Promise
2个月前
Combination Therapies Emerge as a Path to Disease Modification in Parkinson's Disease
去年
Nicotinamide Fails to Show Clear Benefit in Reducing Tau Proteins in Early Alzheimer's Trial
第 1 页，共 7 页
上一页
下一页
